Diabetic nephropathy is associated with increased urinary IGFBP-3 proteolysis, which may increase local IGF bioavailability and contribute to structural kidney changes.
No takes yet. Share an insight, caveat, or question.
Supports IGF system involvement in diabetic nephropathy; hypothesis-generating, needs longitudinal studies before any clinical role.
Shinada et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: